Optimism Grows in the Fight Against Cancer as Breakthroughs and Funding Increase

PR NewswireSep 24 09:15 ET

Maxim Group Maintains Oncolytics Biotech(ONCY.US) With Buy Rating, Maintains Target Price $5

Moomoo NewsSep 20 13:32 ET · Ratings

Buy Rating Affirmed for Oncolytics Biotech on Strong Phase 2 Results and Commercial Potential

TipRanksSep 20 12:45 ET · Ratings

Raymond James Maintains Oncolytics Biotech(ONCY.US) With Buy Rating, Raises Target Price to $2.58

Moomoo NewsSep 20 11:32 ET · Ratings

Global Cancer Rates Surge as Biotech Innovators Work on New Therapies

PR NewswireSep 20 11:08 ET

Express News | Cantor Fitzgerald Reiterates Overweight on Oncolytics Biotech

BenzingaSep 20 10:05 ET